CD274 and ovarian carcinoma: Tumor context further modulates checkpoint biology; in ovarian cancer, intracellular (rather than surface) PD-L1 is enriched within cytotoxic T cells, offering a plausible explanation for the muted activity of conventional PD-1/PD-L1-directed agents in this setting 97.